Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Epigenomics AG - Registered Shares?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Epigenomics AG - Registered Shares market cap is $982,200.00.
What is the 52-week high for Epigenomics AG - Registered Shares?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Epigenomics AG - Registered Shares 52 week high is $1.12 as of September 13, 2025.
What is the 52-week low for Epigenomics AG - Registered Shares?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Epigenomics AG - Registered Shares 52 week low is $0.7896 as of September 13, 2025.
What is Epigenomics AG - Registered Shares stock price today?
Epigenomics AG - Registered Shares stock price today is $1.12.
What was Epigenomics AG - Registered Shares stock price yesterday?
Epigenomics AG - Registered Shares stock price yesterday was $0.95.
What is the PE ratio of Epigenomics AG - Registered Shares?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Epigenomics AG - Registered Shares’s P/E ratio is -0.33.
What is the Price-to-Book ratio of Epigenomics AG - Registered Shares?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Epigenomics AG - Registered Shares P/B ratio is -0.0756.
What is the 50-day moving average of Epigenomics AG - Registered Shares?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Epigenomics AG - Registered Shares 50-day moving average is $1.05.
